Taken together, we proposed a possible molecular mechanism for cisplatin resistance in cervical cancer by which downregulation of NHERF1 promotes overactivation of Wnt/β-catenin signaling and results in cisplatin resistance. Here, NHERF1 is linked to cervical cancer.